Search

Steven J Sawamura

from Newark, CA
Age ~66
Get Report
Also known as:
Steven Junichi Sawamura, Steve J Sawamura
Phone and address:
35301 Farnham Dr, Newark, CA 94560
(510) 648-4345
Related to:
Scott Sawamura, 30Patricia Ann Ward, 64Brian Kenji Sawamura, 28Tadashi Sawamura, 97Regis A WardJoann L Cohen, 57Robin B Sawamura, 67Jaimie S Sawamura, 60Jennifer R Post, 50Jacquelyn E Sawamura, 62Steven V Ward, 63
Connected to:
Blanche I Sawamura, 90Amy J Sawan, 59Emily E Sawan, 28Jad D Sawan, 65Michaelle J Sawan, 60Alhassan Sawaneh, 51Salieu Sawaneh, 81Nisakorn Sawangwai, 45Jalal Sawani, 34

Steven Sawamura Phones & Addresses

  • 35301 Farnham Dr, Newark, CA 94560 (510) 648-4345 (510) 796-5799
  • Reno, NV
  • Davis, CA
  • San Jose, CA
  • Alameda, CA
  • El Dorado, CA
  • Orange, CA
  • Fremont, CA
  • 35301 Farnham Dr, Newark, CA 94560

Work

Position: Production Occupations

Education

Degree: Associate degree or higher

Emails

s***[email protected]

Business Records

Name / Title
Company / Classification
Phones & Addresses
Steven J. Sawamura
President
NEWARK NATIONAL LITTLE LEAGUE, INC
Membership Sport/Recreation Club
Shaleen Sanchez, Newark, CA 94560
35301 Farnham Dr, Newark, CA 94560

Publications

Us Patents

Protein Stabilization Formulations

View page
US Patent:
8435943, May 7, 2013
Filed:
Apr 19, 2011
Appl. No.:
13/089683
Inventors:
Venkata R. Garigapati - Southborough MA, US
Dongling Su - Franklin MA, US
Rehan Khanzada - Middleborough MA, US
Steven J. Sawamura - Newark CA, US
Assignee:
Advanced Technogies and Regenerative Medicine, LLC - Raynham MA
International Classification:
A61K 38/00
A61K 38/16
A61K 38/17
A61K 38/18
US Classification:
514 76, 514 88, 514 89, 514 167, 514 168, 514 169, 514 171, 514 172, 424422, 424423
Abstract:
The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.

Protein Stabilization Formulations

View page
US Patent:
20080147077, Jun 19, 2008
Filed:
Dec 4, 2007
Appl. No.:
11/950127
Inventors:
Venkata R. Garigapati - Southborough MA, US
Dongling Su - Franklin MA, US
Rehan Khanzada - Middleborough MA, US
Steven J. Sawamura - Newark CA, US
International Classification:
A61K 38/00
A61P 19/08
A61L 17/00
US Classification:
606 92, 514 2
Abstract:
The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.

Protein Stabilization Formulations

View page
US Patent:
20130184209, Jul 18, 2013
Filed:
Mar 7, 2013
Appl. No.:
13/788517
Inventors:
Dongling Su - Franklin MA, US
Rehan Khanzada - Middleborough MA, US
Steven J. Sawamura - Newark CA, US
Assignee:
DEPUY SYNTHES PRODUCTS, LLC - Raynham MA
International Classification:
A61K 38/18
US Classification:
514 88, 530399
Abstract:
The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.

Protein Stabilization Formulations

View page
US Patent:
20150079145, Mar 19, 2015
Filed:
Nov 21, 2014
Appl. No.:
14/549903
Inventors:
- Raynham MA, US
Dongling Su - Franklin MA, US
Rehan Khanzada - Middleborough MA, US
Steven J. Sawamura - Newark CA, US
International Classification:
A61K 38/18
A61K 9/19
A61K 47/42
A61K 47/18
A61K 47/26
US Classification:
424422, 514 88
Abstract:
The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.
Control profile
Steven J Sawamura from Newark, CA, age ~66 Get Report